Home News SpyGlass Pharma to Unveil Innovative Drug Delivery Platform for Chronic Eye Conditions at Eyecelerator Prior to the American Academy of Ophthalmology Meeting back to News
minute read
SpyGlass Pharma, a privately-held ophthalmic therapeutics company, today announced it will be unveiling a breakthrough drug delivery platform to treat chronic eye conditions at the Eyecelerator innovation meeting, being held prior to the American Academy of Ophthalmology (AAO) 2022 conference, September 29, in Chicago.
Topics: Press Coverage
1675 North Aurora Court
F731
Aurora, CO 80045
Administration: 720-848-2500
Appointments: 720-848-2020
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
